found that Interleukin-23 (IL-23) receptor and IL-23 signaling pathway may be related to RSA, rheumatoid arthritis and ankylosing spondylitis by affecting the growth and apoptosis of IL-17-producing T-helper-17 cells (28). Here, IL17A is linked to ankylosing spondylitis.